Piperacillin/Tazobactam Teva

Medicinal product

(Invented) name

Piperacillin/Tazobactam Teva

Active substance (s)

Piperacilinas/Tazobaktamas

Strength

4000 mg/500 mg

Pharmaceutical form

milteliai infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01CR05, Piperacillin and beta-lactamase inhibitor

Marketing authorisation holder

Teva Pharma B.V., Nyderlandai

Date of authorisation

2010-07-15

Date of renewal

2014-08-01

Documents

2100 Piperacillin_Tazobactam Teva PCS 2023 09 13.docx

2100 Pakuotės lapelis 2021 12 13.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/0829/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Flakone yra	1 vnt.
Piperacilinas	4000 mg
Tazobaktamas	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
19500	22793	1022793	flakonas	N1		Receptinis	LT/1/10/2100/003	Netiekiama	-	-	No	-	-	Download
19501	22794	1022794	flakonas	N10		Receptinis	LT/1/10/2100/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-05-31	Išregistruotas
2014-08-01	Perregistruotas
2010-07-15	Registruotas